Importantly, Kaplan–Meier analysis of data from TCGA showed that higher expression of MGRN1 in the melanoma samples was associated with shorter survival of patients, and this was further suggested by the direct measurements of MGRN1 expression in the cohort of clinical specimens from the BBHRI reported here. The gene discussed is MGRN1; the disease is melanoma.